Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Fumaritine N-oxide

Fumaritine N-oxide (CAS 60604-88-8) is a research chemical used in life science studies. It serves as a biochemical tool for in vitro investigations, particularly in pharmacological research exploring alkaloid derivatives and their biological activities.

Product Specifications

CAS Number

60604-88-8

Smiles

COc1cc2CC[N+] (C) ([O-]) C3 (Cc4ccc5OCOc5c4C3O) c2cc1O

Molecular Formula

C20H21NO6

Molecular Weight

371.389

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Cyclin G1 polyclonal antibody
orb1718227-01 50 µL

Cyclin G1 polyclonal antibody

Sign In for Pricing
View Details
Cyclin G1 polyclonal antibody
orb1718227-02 100 µL

Cyclin G1 polyclonal antibody

Sign In for Pricing
View Details
Lentiviral mouse AI661453 shRNA (UAS) - Lentiviral mouse AI661453 shRNA (UAS, iRFP) plasmid
GTR15142108 1 Vial

Lentiviral mouse AI661453 shRNA (UAS) - Lentiviral mouse AI661453 shRNA (UAS, iRFP) plasmid

Sign In for Pricing
View Details
Recombinant Neisseria meningitidis serogroup C/serotype 2a Putative 8-amino-7-oxononanoate synthase (bioF)
MBS1081639-01 0.02 mg (E-Coli)

Recombinant Neisseria meningitidis serogroup C/serotype 2a Putative 8-amino-7-oxononanoate synthase (bioF)

Sign In for Pricing
View Details
Recombinant Neisseria meningitidis serogroup C/serotype 2a Putative 8-amino-7-oxononanoate synthase (bioF)
MBS1081639-02 0.02 mg (Yeast)

Recombinant Neisseria meningitidis serogroup C/serotype 2a Putative 8-amino-7-oxononanoate synthase (bioF)

Sign In for Pricing
View Details
Recombinant Neisseria meningitidis serogroup C/serotype 2a Putative 8-amino-7-oxononanoate synthase (bioF)
MBS1081639-03 0.1 mg (E-Coli)

Recombinant Neisseria meningitidis serogroup C/serotype 2a Putative 8-amino-7-oxononanoate synthase (bioF)

Sign In for Pricing
View Details